Details for New Drug Application (NDA): 076254
✉ Email this page to a colleague
NDA 076254 describes BRIMONIDINE TARTRATE, which is a drug marketed by Padagis Israel, Alembic, Apotex, Bausch And Lomb, Dr Reddys Labs Sa, Lupin Ltd, Micro Labs, Regcon Holdings, Rising, Sandoz, Somerset Theraps Llc, Teva Parenteral, Upsher Smith Labs, Amneal, Caplin, Glenmark Pharms Ltd, Sentiss, and Somerset, and is included in twenty-nine NDAs. It is available from eleven suppliers. Additional details are available on the BRIMONIDINE TARTRATE profile page.
The generic ingredient in BRIMONIDINE TARTRATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
The generic ingredient in BRIMONIDINE TARTRATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
Summary for 076254
| Tradename: | BRIMONIDINE TARTRATE |
| Applicant: | Sandoz |
| Ingredient: | brimonidine tartrate |
| Patents: | 0 |
Pharmacology for NDA: 076254
| Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for 076254
Suppliers and Packaging for NDA: 076254
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 076254 | ANDA | Sandoz Inc | 61314-143 | 61314-143-05 | 5 mL in 1 BOTTLE (61314-143-05) |
| BRIMONIDINE TARTRATE | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 076254 | ANDA | Sandoz Inc | 61314-143 | 61314-143-10 | 10 mL in 1 BOTTLE (61314-143-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.2% | ||||
| Approval Date: | Sep 16, 2003 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
